February 7, 2022
Cervical Cancer CIN3 in Young Women Plummeted After HPV Vaccination
Following the introduction of human papillomavirus (HPV) vaccination in England, there was a substantial reduction in cervical cancer and the incidence of grade 3 cervical intraepithelial neoplasia (CIN3), according to a study published in The Lancet. Milena Falcaro, Ph.D., from King’s College London, and colleagues used an extension of the age-period-cohort Poisson model to estimate the...
Cervical Cancer Deaths Down Following HPV Vaccine Introduction
Women and girls aged 15 to 24 years old have decreased cervical cancer incidence and mortality after the introduction of the human papillomavirus (HPV) vaccine, according to a research letter published in JAMA Pediatrics. Tara Tabibi, from the St. Louis University School of Medicine, and colleagues obtained national age-adjusted cervical cancer incidence and mortality data from...
Cervical Cancer Incidence Varies by Neighborhood Wealth
According to a study published in JAMA Oncology, cervical cancer incidence varies significantly between poor and wealthy New York City neighborhoods. Stephanie Cham, M.D., from Brigham and Women’s Hospital/Dana Farber Cancer Institute in Boston, and colleagues quantified the association between neighborhood socioeconomic status (SES) and the incidence of cervical cancer in New York City (2012...
2005 to 2019 Saw Decline in Cervical Cancer Screening Rates
According to a study published online in JAMA Network Open, guideline-concordant cervical cancer screening rates decreased between 2005 and 2019. Ryan Suk, Ph.D., from University of Texas Health Science Center at Houston School of Public Health, and colleagues estimated changes in U.S. Preventive Services Task Force guideline-concordant cervical cancer screening over time using data from the...